MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

STERIS PLC

Geschlossen

BrancheGesundheitswesen

221.06 -2.98

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

220.47

Max

226.95

Schlüsselkennzahlen

By Trading Economics

Einkommen

16M

173M

Verkäufe

42M

1.4B

KGV

Branchendurchschnitt

36.498

63.778

EPS

2.32

Dividendenrendite

1.01

Gewinnspanne

12.643

Angestellte

18,000

EBITDA

-85M

245M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+19.69% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.01%

2.39%

Nächstes Ergebnis

7. Mai 2025

Nächste Dividendenausschüttung

25. Juni 2025

Nächstes Ex-Dividendendatum

11. Juni 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

22B

Vorheriger Eröffnungskurs

224.04

Vorheriger Schlusskurs

221.06

Nachrichtenstimmung

By Acuity

34%

66%

99 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

STERIS PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Feb. 2025, 21:35 UTC

Ergebnisse

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5. Feb. 2025, 21:34 UTC

Ergebnisse

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5. Feb. 2025, 21:34 UTC

Ergebnisse

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5. Feb. 2025, 21:33 UTC

Ergebnisse

Steris 3Q EPS $1.75 >STE

5. Feb. 2025, 21:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5. Feb. 2025, 21:30 UTC

Ergebnisse

Steris 3Q Rev $1.4B >STE

5. Feb. 2025, 21:30 UTC

Ergebnisse

Steris 3Q Adj EPS $2.32 >STE

6. Nov. 2024, 21:41 UTC

Ergebnisse

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6. Nov. 2024, 21:40 UTC

Ergebnisse

Steris 2Q EPS $1.51 >STE

6. Nov. 2024, 21:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6. Nov. 2024, 21:30 UTC

Ergebnisse

Steris 2Q Adj EPS $2.14 >STE

6. Nov. 2024, 21:30 UTC

Ergebnisse

Steris 2Q Rev $1.3B >STE

6. Aug. 2024, 20:36 UTC

Ergebnisse

Steris 1Q Adj EPS $2.03 >STE

6. Aug. 2024, 20:30 UTC

Ergebnisse

Steris 1Q Net $139.9M >STE

6. Aug. 2024, 20:30 UTC

Ergebnisse

Steris 1Q EPS $1.41 >STE

6. Aug. 2024, 20:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3. Juni 2024, 11:03 UTC

Akquisitionen, Fusionen, Übernahmen

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31. Mai 2024, 20:47 UTC

Akquisitionen, Fusionen, Übernahmen

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

8. Mai 2024, 20:40 UTC

Ergebnisse

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

8. Mai 2024, 20:39 UTC

Ergebnisse

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

8. Mai 2024, 20:39 UTC

Ergebnisse

Steris Announcing a Targeted Restructuring Plan >STE

8. Mai 2024, 20:39 UTC

Ergebnisse

Steris 4Q EPS $3.81 >STE

8. Mai 2024, 20:30 UTC

Ergebnisse

Steris 4Q Adj EPS $2.58 >STE

11. Apr. 2024, 11:01 UTC

Akquisitionen, Fusionen, Übernahmen

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

11. Apr. 2024, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

11. Apr. 2024, 10:59 UTC

Akquisitionen, Fusionen, Übernahmen

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

11. Apr. 2024, 10:59 UTC

Akquisitionen, Fusionen, Übernahmen

Steris: Transaction Is Structured as Equity Sale >STE

11. Apr. 2024, 10:58 UTC

Akquisitionen, Fusionen, Übernahmen

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

11. Apr. 2024, 10:58 UTC

Akquisitionen, Fusionen, Übernahmen

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Peer-Vergleich

Kursveränderung

STERIS PLC Prognose

Kursziel

By TipRanks

19.69% Vorteil

12-Monats-Prognose

Durchschnitt 265 USD  19.69%

Hoch 265 USD

Tief 265 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für STERIS PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

220.42 / 223.4Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

99 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.